Skin cancer prevention involves a suite of measures to shield the skin from the adverse effects of UV radiation. Prioritizing prevention is essential for overall health and well-being.
UV radiation inflicts damage on the DNA of skin cells, promoting the development of skin cancer. The accumulation of these mutations over time heightens the risk of cancer.
DermTech uses molecular analysis to evaluate the risk of skin cancer by probing genetic markers within skin lesions. SkinIO, an app-based solution, facilitates skin health monitoring over time, harnessing AI to detect potential signs of skin cancer.
DermTech is a non-invasive procedure that procures samples from suspicious skin lesions through an adhesive patch. These samples subsequently undergo molecular analysis to pinpoint genetic markers associated with the risk of skin cancer, facilitating a more precise prevention approach.
Routine monitoring using SkinIO enhances the ability to thwart skin cancer by enabling the tracking of skin changes over time. The app’s AI analysis aids in the early detection of potential skin cancer indicators, empowering individuals to seek medical attention promptly.
Absolutely, both DermTech and SkinIO are designed to benefit individuals of all ages and skin types. They provide tailored insights and tools to support proactive skin cancer prevention efforts.
